Trials / Completed
CompletedNCT01260259
Seattle Cardiorenal Remote Ischemic Preconditioning Trial
Effect of Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Seattle Children's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Remote Ischemic Preconditioning (RIPC) is a treatment that may be associated with improved outcomes after cardiac surgery. It can be elicited noninvasively by using a tourniquet to elicit transient ischemia over a lower extremity. It is thought to promote anti-inflammatory and cell survival pathways, and thus protect remote organs against future ischemic injury. We hypothesize that compared to sham treatment, RIPC will be associated with decreased post-operative acute kidney, myocardial, and lung injury.
Detailed description
In children undergoing cardiac surgery and cardiopulmonary bypass (CPB), our primary aims are to determine whether RPC is associated with: 1) decreased AKI and 2) decreased acute myocardial injury. Secondary aims include investigating the effects of RPC on post-procedure: 1)acute lung injury and 2) morbidity/mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | RIPC | RIPC will be elicited in the operating room (OR) after anesthesia induction and before start of surgery. After placement of an arterial line, a tourniquet will be placed over a lower extremity. It will be inflated to 15 mmHg above systolic blood pressure for 5 minutes, and then deflated for 5 minutes. This cycle of inflation-deflation will be repeated another 3 times before surgery. |
| PROCEDURE | Control | In OR, after induction of general anesthesia and arterial line placement, a deflated tourniquet will be placed over the lower extremity for 40 minutes. |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2010-12-15
- Last updated
- 2013-09-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01260259. Inclusion in this directory is not an endorsement.